Mitochondrial Genome Engineering: The Revolution May Not Be CRISPR-Ized

Area of Science:

• Mitochondrial biology and genetics
• Molecular medicine
• Gene editing technologies

Background:

• Mitochondria are central to cellular biochemistry and implicated in disease.
• Mitochondrial DNA (mtDNA) manipulation is gaining interest for therapeutic and research purposes.
• Current methods for engineering mtDNA face significant hurdles, particularly in delivery.

Purpose of the Study:

• To review the current state of mitochondrial DNA (mtDNA) engineering.
• To highlight the challenges and potential of delivering nucleic acids into mitochondria.
• To discuss the implications for developing mitochondria-targeted gene editing tools.

Main Methods:

• Review of existing literature on mtDNA manipulation and delivery systems.
• Analysis of protein-only nucleases (mtZFN, mitoTALEN) efficacy in mitochondria.
• Discussion of the feasibility of a mitochondria-adapted CRISPR/Cas9 system.

Main Results:

• Protein-only nucleases demonstrate effectiveness within mammalian mitochondria.
• Efficient delivery of nucleic acids into mitochondria remains a significant, unsolved challenge.
• The existence of endogenous nucleic acid import mechanisms in mitochondria is debated.

Conclusions:

• Advancements in mtDNA engineering hinge on overcoming nucleic acid delivery barriers.
• A functional mitochondria-adapted CRISPR/Cas9 system could revolutionize mitochondrial biology.
• Further research is needed to elucidate endogenous mitochondrial nucleic acid import pathways.